PD‐1, an immune checkpoint molecule expressed on T cells, inhibits T‐cell activation when it binds to PD‐L1, which is expressed on tumor cells, allowing tumor cells to evade immune detection. The gene discussed is PDCD1; the disease is neoplasm.